Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2014
08/21/2014WO2014124860A1 Specific pde4b-inhibitors for the treatment of diabetes mellitus
08/21/2014WO2014102312A3 Minimally toxic prodrugs
08/21/2014WO2014091388A3 Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
08/21/2014WO2014083567A8 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140235726 Method of improving cognition and increasing dendritic complexity in humans with down syndrome and compositions therefor
08/21/2014US20140235719 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
08/21/2014US20140235714 Cancer therapy
08/21/2014US20140235702 Small molecule inhibitors of mcl-1 and the uses of thereof
08/21/2014US20140235688 Treatment of external parasites by oral administration of parasiticidal agents
08/21/2014US20140235681 Combination therapy for glaucoma
08/21/2014US20140235676 Rxr agonist compounds and methods
08/21/2014US20140235671 Scriptaid isosteres and their use in therapy
08/21/2014US20140235664 Stable pharmaceutical formulations of methylnaltrexone
08/21/2014US20140235660 Compounds and compositions as selective estrogen receptor degraders
08/21/2014US20140235650 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
08/21/2014US20140235646 Methods and Compositions for the Treatment of Body Weight Related Disorders
08/21/2014US20140235631 Efflux inhibitor compositions and methods of treatment using the same
08/21/2014US20140235625 Modulators of cystic fibrosis transmembrane conductance regulator
08/21/2014US20140235616 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
08/21/2014US20140235606 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide
08/21/2014US20140235601 Use of Aromatase Inhibitor Or Estrogen Blocker For Increasing Spermatogenesis Or Testosterone Levels In Males
08/21/2014US20140235597 Ophthalmologic Irrigation Solutions and Method
08/21/2014US20140235593 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
08/21/2014US20140235590 Pharmaceutical compounds for use in the therapy of clostridium difficile infection
08/21/2014US20140235582 Hiv replication inhibitors
08/21/2014US20140235569 Composition and methods for the production of s-adenosylmethionine within the body
08/21/2014US20140235567 5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
08/21/2014US20140235564 Methods for treating neural cell swelling
08/21/2014US20140235558 Pharmaceutical composition having activity of anticancer
08/21/2014US20140235556 Compositions and methods of treating gliomas
08/21/2014US20140235554 Ophthalmic formulation derived from silk protein
08/21/2014US20140235541 Compositions and methods for treatment of aortic fibrosis
08/21/2014US20140235534 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/21/2014US20140235533 Dihydrofuran derivatives as insecticidal compounds
08/21/2014US20140234443 5-ht3 receptor modulators, methods of making, and use thereof
08/21/2014US20140234406 NOVEL NANOPARTICULATE SUSPENSION FOR INCORPORATING FAT-SOLUBLE VITAMINS IN THE TREATMENT OF HAIR THINNING and HAIR LOSS
08/21/2014US20140234402 Intravenous Infusion of Curcumin and a Calcium Channel Blocker
08/21/2014US20140234351 Cancer vaccines and vaccination methods
08/21/2014US20140234350 Ovarian cancer vaccines and vaccination methods
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/21/2014US20140234324 Methods for treating a tumor using an antibody that specifically binds grp94
08/21/2014US20140234322 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
08/21/2014US20140234311 Albumin variants
08/21/2014US20140234308 Treatment of breast cancer with companion diagnostic
08/21/2014US20140234303 Treatment of neurological conditions
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234297 Antibody constant domain regions and uses thereof
08/21/2014US20140234295 Isoflavonoid compounds and methods for the treatment of cancer
08/21/2014US20140234293 Combination Therapy Using Immunoglobulin and C1-Inhibitor
08/21/2014US20140234280 Compositions and Methods for Controlling Infections
08/21/2014US20140234275 Method for treating als via the increased production of factor h
08/21/2014US20140234270 Treatment wth alphat selective ligands
08/21/2014US20140234254 Heteroaromatic compounds as pi3 kinase modulators and methods of use
08/21/2014US20140234253 Combination Treatments For Hepatitis C
08/21/2014US20140234251 Purine nucleoside analogues for treating flaviviridae including hepatitis c
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014US20140234213 Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
08/21/2014US20140234208 Dual variable domain immunoglobulins and uses thereof
08/20/2014EP2767291A2 Treatment of glycogen storage disease type II
08/20/2014EP2766040A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
08/20/2014EP2766039A1 Compositions for the treatment of rheumatoid arthritis and methods of using same
08/20/2014EP2766035A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
08/20/2014EP2766027A1 Raising and diagnosing of serotonin level
08/20/2014EP2766026A1 Prevention and diagnosis of visceral fat
08/20/2014EP2766016A1 Improved sperm function/activity
08/20/2014EP2766015A1 2-carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases
08/20/2014EP2765987A1 Compositions for the treatment of dry eye
08/19/2014US8809562 Use of metallocene compounds for cancer treatment
08/19/2014US8809530 Compositions of protein receptor tyrosine kinase inhibitors
08/19/2014US8809351 Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
08/19/2014US8809324 Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809311 Nutritional supplements
08/19/2014US8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
08/19/2014US8809287 Compositions and methods for altering Wnt autocrine signaling
08/19/2014US8809281 Small peptides and methods for blocking IGE mediated activation of an immune cell
08/19/2014US8809265 Methods for treating HCV
08/19/2014US8809035 Canine probiotic Bifidobacterium
08/19/2014US8809011 HIFα hydroxylation assay
08/19/2014US8808753 Methods for treating pustular psoriasis
08/19/2014US8808750 Microporous zirconium silicate for the treatment of hyperkalemia
08/19/2014US8808741 Tamper resistant dosage forms
08/19/2014US8808710 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
08/19/2014US8808703 Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc
08/19/2014US8808692 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014CA2709865C Method for improved breast milk feeding to reduce the risk of allergy
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2475338C Treatment of ophthalmic disorders using urea and urea derivatives
08/19/2014CA2334872C Use of exendin-4 to treat impaired glucose tolerance
08/14/2014WO2014124144A1 Methods for enhancing an immune response to an antigen
08/14/2014WO2014123500A1 Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid
08/14/2014US20140228431 Method of treating constipation
08/14/2014US20140228421 Methods For Inhibiting Native And Promiscuous Uptake Of Monoamine Neurotransmitters
08/14/2014US20140228415 Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo Efficacy
08/14/2014US20140228402 Combinations Comprising a S1P receptor modulator
08/14/2014US20140228394 Inhibitors of cyp 17
08/14/2014US20140228386 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 1151